ArticleJournal of clinical medicine research2026
Rhabdomyolysis and Acute Kidney Injury: A Retrospective Cohort Study at a Tertiary University Hospital.
Article in Journal of clinical medicine research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical phenotypes and risk stratification for limb-threatening outcomes in acute compartment syndrome: a multicenter externally validated study.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rhabdomyolysis is a serious condition caused by rapid skeletal muscle breakdown, releasing substances like creatine kinase (CK) and myoglobin into the blood. If not recognized or treated, it can lead to acute kidney injury (AKI), which significantly increases health risks. This study systematically examines the epidemiology, causes, and key kidney-related outcomes of rhabdomyolysis at a tertiary university hospital. Methods: We performed a retrospective observational cohort study at the University Hospital Brandenburg, Germany, including hospitalized patients from January 1, 2023, to December 31, 2024. Inclusion required a total CK activity ≥ 500 U/L, a threshold reported in the literature to indicate increased risk for clinically relevant kidney dysfunction. Clinical endpoints were AKI as defined by the Kidney Disease: Improving Global Outcomes (KDIGO) criteria (2012), the need for kidney replacement therapy (KRT) and recovery of kidney function (ROKF). Results: Of 100 included patients (mean age 67.1 ± 19.4 years; 37% female), 60% developed AKI (KDIGO 1: 25.0%, 2: 36.7%, 3: 38.3%). AKI was significantly associated with higher age, cardiovascular/metabolic comorbidities, and elevated inflammatory and myoglobin markers. Lower urine pH in AKI patients suggests a role for aciduria in renal injury. While 49% of AKI patients showed renal recovery, 12% of the total cohort required KRT. KRT requirement was associated with younger age and higher creatinine levels, but not with peak CK or myoglobin values. Absent or incomplete renal recovery was significantly linked only to higher initial and peak creatinine levels. Conclusions: In this tertiary university care cohort, AKI was common among rhabdomyolysis patients, especially older individuals and those with cardiovascular or metabolic conditions. Inflammatory markers, myoglobin levels, and urine pH were key predictors of AKI. Despite intensive care, many required KRT and experienced incomplete renal recovery. Early diagnosis, risk stratification, and standardized criteria are needed to improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.